Diamyd Medical AB (publ)

kr 0.98As of Sun 8 Nov 2026, 12:00 UTC
STO:DMYD-BHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (16.53%)
Div yield —
ROE (97.63%)
Biotechnology
Beta (5Y) 2.14
PE TTM —
TSR TTM (90.40%)
Mkt cap kr 151.4M
ROIC (61.49%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.94
(3.75%)
(38.27%)
Buy 11|6|7|5|1
1Q26
2Q26
3Q26
4Q26
Earnings per sharekr
0.01
0.01
0.01
0.01
21.02%
13.52%
19.85%
21.24%
Revenuekr M
10.29
10.08
10.44
10.92
8.79%
1.62%
6.86%
9.81%
Peers (US$15.31M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
11.59
0.038
0.038
EBIT/Intx
1.577
0.126
0.140
Own earn%
14.14
(42.26)
(57.00)
Sh yield%
14.58
35.06
35.97
Owners
Insiders/Inst%
8.81
38.98
Short interest%
0.58
SBC / revenue%
3.75
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
14–27
$1 testx
—
Incr. ROIC%
6